Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

ES Doce 120 Injection Combipack

Prescription Icon
Prescription Required

Marketer

Esperer Bioresearch Pvt Ltd

Salt Composition

Docetaxel (120mg)

Overview ES Doce 120 Injection Combipack

The combination injection, ES Doce 120, is a chemotherapy agent indicated for various cancers, including breast, non-small cell lung, prostate, and head and neck malignancies. Administration is strictly by injection from a qualified healthcare provider. Dosage and frequency are determined individually by your physician based on your specific condition and may be adjusted over time. Adhere precisely to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include fatigue, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and general weakness. Concomitant medications may be prescribed to mitigate these effects. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever to your physician immediately. This medication can suppress blood cell production (red and white blood cells), increasing infection risk. Regular blood tests are necessary to monitor blood counts and liver function. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of other medications, especially antibiotics or antifungals, to your doctor. Interactions with numerous other drugs are possible. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is crucial for both partners during treatment to prevent conception.

Primary Ingredients of ES Doce 120 Injection Combipack

No information provided. Please provide the text you wish me to rephrase.

Uses of ES Doce 120 Injection Combipack

Cancers of the breast, lung (non-small cell), prostate, and head and neck.

Major Benefits of ES Doce 120 Injection Combipack:

The medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.

Common Side effects of ES Doce 120 Injection Combipack:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use ES Doce 120 Injection Combipack:

Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.

How ES Doce 120 Injection Combipack works:

ES Doce 120 Injection Combipack is a cancer treatment that disrupts the microtubule networks essential for cancer cell division and proliferation. This inhibits cancer cell growth, leading to their eventual demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of ES Doce 120 Injection Combipack and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing ES Doce 120 Injection Combipack during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Administration of ES Doce 120 Injection Combipack while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of ES Doce 120 Injection Combipack on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

ES Doce 120 Injection Combipack poses no safety concerns for patients with renal impairment; therefore, no dosage alteration is necessary.

LiverLiverCAUTION

Exercise caution when administering the ES Doce 120 Injection Combipack to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take ES Doce 120 Injection Combipack :

NA

Facts to Know About ES Doce 120 Injection Combipack

LabelValue
Chemical Type Taxane Derivatives
Developing Habits No.
Treatment Category Cancer Medications
Behavior Class Taxanes: Antimicrotubule Agents

FAQs on ES Doce 120 Injection Combipack

ES Doce 120 Injection Combipack can cause weight gain, often starting with swollen feet due to fluid retention, which may subsequently spread throughout the body. Contact your doctor promptly if you experience foot swelling.
Follow your doctor's instructions regarding the continued use of ES Doce 120 Injection Combipack. Treatment length depends on your cancer type and response to therapy. Infusions are typically administered every three weeks.
ES Doce 120 Injection Combipack contains alcohol, potentially causing drowsiness, confusion, dizziness, and impaired coordination similar to alcohol intoxication. Driving or operating machinery should be avoided immediately following injection. Alcohol consumption should be avoided throughout your ES Doce 120 Injection Combipack treatment to prevent adverse effects.
ES Doce 120 Injection Combipack treats various cancers, including breast, lung, prostate, stomach, and head and neck cancers, by inhibiting cell growth and proliferation.
ES Doce 120 Injection Combipack is a liquid administered intravenously by a healthcare professional in a hospital or clinic setting. Infusion typically takes one hour, administered once every three weeks.
Before each scheduled ES Doce 120 Injection Combipack dose, your doctor will order blood tests (including a hemogram and liver function tests) to monitor your blood cell counts and liver function. Low white blood cell counts can cause fever or infection.
ES Doce 120 Injection Combipack may cause hair loss, a common side effect. Hair typically regrows after treatment ends, but permanent hair loss is possible. Discuss any hair loss concerns with your doctor.
ES Doce 120 Injection Combipack can cause swelling (hands, feet, ankles, legs) and severe allergic reactions. To mitigate these risks, all patients receive corticosteroids (dexamethasone) for three days, beginning one day before treatment. For metastatic castration-resistant prostate cancer, dexamethasone is administered orally 12, 3, and 1 hour before ES Doce 120 Injection Combipack infusion.
ES Doce 120 Injection Combipack is a taxoid, a type of anti-cancer medication. It inhibits cancer cell growth and spread.
ES Doce 120 Injection Com...
20,196